100 Clinical Results associated with Chinoin Pvt Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Chinoin Pvt Co. Ltd.
Login to view more data
19
Literatures (Medical) associated with Chinoin Pvt Co. Ltd.
01 Apr 2008·SYNTHETIC COMMUNICATIONS
Catalytic Transfer Hydrogenation and Hydrogenolysis in Ionic Liquids with Pd/MgLa Mixed Oxide and Pd/MgAl Hydrotalcite as Recyclable Catalysts
Author: Hermecz, István ; Baán, Zoltán ; Cwik, Agnieszka ; Potor, Attila ; Keglevich, György ; Finta, Zoltán ; Hell, Zoltán
A new Pd/MgLa mixed oxide and the known Pd/MgAl hydrotalcite catalysts were applied and recycled successfully in catalytic transfer hydrogenation reactions in ionic liquidsSome α,β-unsaturated carboxylic acid derivatives were hydrogenated in excellent yields.The catalysts were recycled without significant loss of activity.Besides that, a number of halogenated aromatic compounds were dehalogenated under similar catalytic transfer conditions.
01 Jan 2003·Advances in Heterocyclic Chemistry
Recent Development in the Chemistry of Pyrido-oxazines, Pyrido-thiazines, Pyrido-diazines and Their Benzologs: Part 1
Author: Hermecz, Istvan
A review on structure, reactivity, and synthesis of pyrido-oxazines, pyrido-thiazines, pyrido-diazines and their benzologs is presented.
01 Oct 2001·The Journal of organic chemistryQ2 · CHEMISTRY
Novel Intramolecular Rearrangement of Tertiary PropargylamineN-Oxides
Q2 · CHEMISTRY
Article
Author: Hermecz, István ; Szabó, Anna
The formation of enamino aldehydes and acrylamides from tertiary propargylamine N-oxides in protic media can be interpreted as a novel prototropic rearrangement.The proposed rearrangement mechanism is supported by isotopic labeling experiments and by relevant literature data.
100 Deals associated with Chinoin Pvt Co. Ltd.
Login to view more data
100 Translational Medicine associated with Chinoin Pvt Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.